Medical Treatments for Prostate Cancer

There are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.

Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy.

The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped.

bone metastasis of prostate cancer
Targeting Bone Metastasis in Prostate Cancer with Endothelin
Recent advances in the understanding of prostate cancer biology and its progression to bone metastasis have led to the development of drugs directed against

Bone Metastases - Prostate Cancer Research Foundation
Cancer makes bones prone to fractures. The main symptom of bone metastases is pain which can severely affect quality of life.

Survival markers related to bone metastases in prostate cancer
Survival markers related to bone metastases in prostate cancer. EK SALMINEN, MJ KALLIOINEN, MA ALA-HOUHALA, PP VIHINEN, SL TIITINEN, M VARPULA, TJ VAHLBERG

Pathogenesis and treatment of prostate cancer bone metastases
The propensity of prostate cancer cells to metastasize to bone is leading to the design of novel therapies targeting both the cancer cell as well as the

UpToDate Management of bone metastases in advanced prostate cancer
We will discuss the evaluation and treatment of bone metastases in men with prostate cancer here. Most of this discussion is applicable to men whose disease

Targeted Antibody Inhibition of Bone Metastases by Prostate Cancer
Metastasis to bone is a major cause of morbidity from prostate cancer. - Parathyroid hormone-related protein (PTHrP) is expressed by prostate cancer cells

Prostate cancer and bone metastases: medical treatment.
Work is ongoing to improve other approaches to the medical treatment of bone metastases in patients with advanced prostate cancer including the use of

Hormone-Refractory Prostate Cancer with Bone Metastases - Prostate
Newer Concepts in the Treatment of Hormone-Refractory Prostate Cancer with Bone Metastases: Combinations of Bone-Seeking Radiopharmaceuticals and

b. Treating Bone Metastases - Prostate Cancer Foundation
There are a few different kinds of treatments for prostate cancer bone metastases.

Managing Bone Metastases and Pain - Prostate Cancer Foundation
In prostate cancer, metastases to the bones of the pelvis, spine and ribs are especially common. These bone metastases make the bone more susceptible to

Osteoblasts in Prostate Cancer Metastasis to Bone
Metastases from prostate cancer, most of which are adenocarcinomas, nearly always form osteoblastic lesions in bone; by contrast, bone metastases from

eMedicine - Prostate Cancer: Metastatic and Advanced Disease
Regardless of these guidelines, a bone scan is indicated in patients with prostate cancer who have symptoms suggesting bony metastases. Activity in the bone

Advanced Prostate Cancer: Understanding Prostate Cancer Metastasis
Advanced prostate cancer with bone metastasis or lymph node metastasis is more Advanced prostate cancer bone metastasis and lymph node metastasis,

National Prostate Cancer Coalition: Advanced Prostate Cancer: Bone
To learn about research into new ways to treat bone metastasis, please visit the following pages in our new Research Section:. Prostate Cancer Research:

Bonetumor.org - The Web's Most Comprehensive Bone Tumor Resource
PSA is also currently the most useful marker for assessing the level of bone involvement in prostate cancer. Diagnosis of bone metastases is accomplished by

Bonetumor.org - The Web's Most Comprehensive Bone Tumor Resource
The sluggish blood flow in this plexus is more conducive to tumor survival, accounting for the high rate of prostate cancer metastasis to the spine.

ACS :: What Is Bone Metastasis?
For example, if prostate cancer spreads to the bones, it is still called prostate cancer, Primary bone cancer is much less common than bone metastasis.

ACS :: How Is Bone Metastasis Treated?
Osteoblastic metastases occur most frequently in prostate cancer that has spread to bone. They are found less often in breast cancer that has spread to bone


bone metastasis of prostate cancer
greenlight prostate
bph benign prostate
cum erection prostate stirrups
cancer herbal prostate treatment